Neptune Medical
PrivateLast Round
Series D
Aug 15, 2024
Est. Valuation
$387M
Total Funding Raised
$97M
Company Overview
Neptune Medical is a medical device company that develops, manufactures, and commercializes innovative gastroenterology solutions, including its proprietary Dynamic Rigidization technology for endoscopic procedures.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neptune Medical Comparables
Compare Neptune Medical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EndoQuest Robotics | 83% | |
| EndoStart | 78% | |
| Swan EndoSurgical | 77% |
Neptune Medical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Aug 15, 2024 |
Key People
Founding team and executive leadership
Neptune Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sonder Capital | Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2026
Pathfinder device cleared by the FDA.
- Mar 1, 2026
Developing Triton Robotic Endoscopy, a flexible medical robot.
Neptune Medical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Neptune Medical's valuation, stock price, and market status.
Is Pathfinder a public or private company?
Pathfinder is a private company.
What is the current stock price of Pathfinder?
Pathfinder is a private company with no public stock price. No recent secondary market data is available.
How much is Pathfinder worth (valuation)?
Pathfinder's valuation is estimated at $387.0M based on funding round data.
Can I buy Pathfinder stock?
Pathfinder shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Pathfinder's last funding round?
Pathfinder's most recent funding round was Series D on August 15, 2024.
Who are the main investors in Pathfinder?
Key investors in Pathfinder include Sonder Capital.
Will Pathfinder IPO soon?
No public IPO plans have been announced for Pathfinder.
How can I track Pathfinder secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Pathfinder's secondary market activity and sign up for updates.